"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Asklepios Klinik Harburg conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Klinik Harburg" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Aeris Therapeutics" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Morphotek" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Harburg" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Harburg" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Aortic Valve Disease" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Peripheral Arterial Disease" (2 trials) and "Pulmonary Emphysema" (2 trials). Many other conditions were trialed in "Asklepios Klinik Harburg" in a lesser frequency.

Most popular intervention types in "Asklepios Klinik Harburg" are "Drug" (16 trials), "Device" (9 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Cisplatin" (4 trials), "Pemetrexed" (4 trials), "Placebo" (4 trials) and "Erlotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Klinik Harburg" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Asklepios Klinik Harburg". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Asklepios Klinik Harburg, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Klinik Harburg, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".